Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in Thailand
Conditions:   Plasmodium Falciparum Malaria;   Plasmodium Vivax Malaria Interventions:   Other: Case Management and Follow-up;   Other: Reactive focal mass drug administration (rfMDA) Sponsors:   University of California, San Francisco;   Center for Malariology, Parasitology, and Entomology;   Tulane University School of Public Health and Tropical Medicine;   University of Massachusetts, Amherst;   Centers for Disease Control and Prevention Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2021 Category: Research Source Type: clinical trials